Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-22T16:08:02.752Z Has data issue: false hasContentIssue false
  • English
  • Français

The Use of Psychiatric Drugs for Decades

Published online by Cambridge University Press:  29 January 2018

Peter Kennedy
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Comments
Information
The British Journal of Psychiatry , Volume 137 , Issue 4 , October 1980 , pp. 387 - 389
Copyright
Copyright © Royal College of Psychiatrists, 1980 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Avery, D. & Winokur, G. (1976) Mortality in depressed patients treated with ECT and antidepressants. Archives of General Psychiatry, 33, 1029–37.CrossRefGoogle ScholarPubMed
Ayd, F. J. (1970) Prevention of recurrence. In Clinical Handbook of Psychopharmacology, 297–310 (eds. Dimascio, and Shader, ). New York: Science House.Google Scholar
Ayd, F. J. (1974) International Drug Therapy Newsletter, 9, 8.Google Scholar
Birch, N. J. (1980) Bone side effects of lithium. In Handbook of Lithium Therapy, (ed. Johnson, ). MTP Press.Google Scholar
British Medical Journal (1980) Use of antidepressants in schizophrenia, 280, 1037–8.Google Scholar
Brown, G. W., Birley, J. L. T., Wing, J. K. (1972) Influence of family life on the course of schizophrenia. British Journal of Psychiatry, 121, 241–58.Google Scholar
Crane, G. E. (1973) Persistent dyskinesia. British Journal of Psychiatry, 122, 395–405.Google Scholar
Cunningham-Owens, D. G. & Johnstone, E. C. (1980) The disabilities of chronic schizophrenia—their nature and the factors contributing to their development. British Journal of Psychiatry, 136, 384–95.Google Scholar
Davis, J. M. (1975) Overview: Maintenance therapy in psychiatry: I. Schizophrenia. American Journal of Psychiatry, 132, 1237–45.Google Scholar
Davis, J. M. (1976) Overview: Maintenance therapy in Psychiatry: II. Affective disorders. American Journal of Psychiatry, 133, 1–13.Google ScholarPubMed
Glen, A. I. M., Dodd, M., Hulme, E. B. & Kreitman, N. (1979) Mortality on lithium. Neuropsychobiology, 5, 167–73.CrossRefGoogle ScholarPubMed
Jeste, D. V., Potkin, S. G., Sinha, S., et al (1979) Tardive dyskinesia: reversible and persistent. Archives of General Psychiatry, 36, 585–90.CrossRefGoogle ScholarPubMed
Johnson, D. A. W. (1977) Practical considerations in the use of neuroleptics for treatment of schizophrenia. British Journal of Hospital Medicine, 546–58.Google Scholar
Johnson, D. A. W. (1979) Further observations on the duration of neuroleptic maintenance therapy in schizophrenia. British Journal of Psychiatry, 135, 524–30.Google Scholar
Lancet (1979) Lithium and the kidney: grounds for cautious optimism, 1056–7.Google Scholar
Lindstedt, G., Nilsson, L., Walinder, J., et al (1977) On prevalence, diagnosis and management of lithium induced hypothyroidism in psychiatric patients. British Journal of Psychiatry, 130, 452–8.Google Scholar
McClelland, H. A., Blessed, G., Bhate, S., et al (1974) The abrupt withdrawal of antiparkinsonian drugs in schizophrenia. British Journal of Psychiatry, 124, 151–9.CrossRefGoogle Scholar
Perris, C., Dimitrijevic, P., Jacobsson, L., et al (1979) Tardive dyskinesia in psychiatric patients treated with neuroleptics. British Journal of Psychiatry, 122, 395–405.Google Scholar
Schiff, A. A. (1980) British Journal of Psychiatry Corr., 136, 522.Google Scholar
Shaw, D. M. (1977) The practical management of affective disorders. British Journal of Psychiatry, 130, 432–51.Google Scholar
Simpson, G. M., Varga, E., Lee, H. L. & Zoubok, B. (1978) Tardive dyskinesia and psychotropic drug history. Psychopharmacology, 58, 117–24.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.